1. Home
  2. OCX

OCX

Oncocyte Corporation

Logo Oncocyte Corporation

Health Care

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Nasdaq

as 04-12-2024 11:31am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States.

Founded: 2009 Country:
United States
United States
Employees: N/A City: IRVINE
Market Cap: 24.0M IPO Year: N/A
Target Price: $3.87 AVG Volume (30 days): 8.6K
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -9.48 EPS Growth: N/A
52 Week Low/High: $2.08 - $6.90 Next Earning Date: 05-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 59.5% Revenue Growth (next year): 49.61%

Share on Social Networks: